【中航-2025研报】KC1086获批FDA临床批准，源头创新能力显现.pdfVIP

◆

◆

◆

◆

1

◆

◆

现金流量表

资本支出112.56108.2575.090.000.00-0.00

自由现金流-21.46-59.61156.53259.17291.91318.57

短期借款增加0.0096.9344.0339.33-101.00-79.29

长期带息债务增加-7.4140.0816.86-15.77-15.27-14.72

股权筹资额0.000.000.00

支付普通股股利31.3047.6995.53134.07169.66203.03

长期投资-228.20-346.82-94.4113.4313.4313.43

经营性现金净流量113.00192.21167.02283.49348.25387.05

投资性现金净流量-324.51-447.72-198.4013.4313.4313.43

筹资性现金净流量-56.89143.62-8.27-119.08-291.98-298.13

现金流量净额-269.15-113.25-42.46177.8469.71102.35

货币资金的期初余额595.79333.33227.22189.98367.81437.52

货币资金的期末余额345.25230.20189.98367.81437.52539.87

企业自由现金流-21.46-59.61156.53259.17291.91318.57

权益自由现金